By jwhitleAs the fourth year of the AIM-Bio Program concludes, the AIM-Bio project management team has created a set of dashboards to highlight key metrics for... |2023 Q4
By jwhitleDTU hosted the 4th annual AIM-Bio Biopharmaceutical Manufacturing Symposium Oct. 30–31, 2023. Faculty, staff, and students from NC State were excited to travel to Denmark... |2023 Q4
By jwhitleDTU and NC State offer a variety of biotech lifelong learning courses, and 2024 courses are now open for enrollment. These courses increase the knowledge... |2023 Q3
By jwhitleThe AIM-Bio Steering Committee invites you to attend the fourth annual AIM-Bio Biopharmaceutical Manufacturing Symposium, which will be held at the Technical University of Denmark (DTU) on... |2023 Q3
By jwhitleThe AIM-Bio program initiated a successful collaboration between the Technical University of Denmark and North Carolina State University in 2020. Interestingly, other collaborations and synergies... |2023 Q3
By jwhitleTechnological advancements in the field of mass spectrometry (MS) have resulted in MS-based assays playing an integral role in biotherapeutics development and manufacturing. With the... |2023 Q2
By jwhitleBeginning in April 2023, four NC State PhD students participating in the AIM-Bio exchange program have traveled to the Technical University of Denmark (DTU) for a six-month visit. The students, who are all pursuing doctorates in chemical engineering, are conducting research in the labs of Dr. John Woodley and Dr. Steffen Goletz. Three of the students are advised by Dr. Stefano Menegatti, Associate Professor and University Faculty Scholar at NC State, who is on sabbatical in Denmark to collaborate with AIM-Bio researchers and explore research translation opportunities with companies in Europe. Read on to learn more about the students and their research interests. |2023 Q2
By jwhitleContemporary process analytical technologies (PATs) for biomanufacturing are available for continuously monitoring a small set of analytical targets or are limited by costly and time-consuming offline efforts. With the prime focus of the biopharmaceutical industry crystallizing around monoclonal antibodies and cell/gene therapies and the need for nimble, efficient production platforms, it is more relevant than ever to create scalable, in-line, and high throughput quantification methods. Learn about the AIM-Bio research that is underway at NC State in the lab of Dr. Michael Daniele, associate professor in the Department of Electrical and Computer Engineering. |2023 Q2
By jwhitleDTU and NC State delivered four AIM-Bio lifelong learning courses in March and April 2023. The 48 participants enrolled included 28 working professionals and 20 graduate students. The four courses — Biopharmaceutical Lyophilization and Spray Drying, Upstream Process Development for Biopharmaceutical Production, Biomanufacturing Operations and cGMP, and Automation and Control of Yeast Fermentation —included both significant hands-on laboratory experiences and classroom instruction. Read the full article to learn about the courses and attendees’ countries of origin. |2023 Q1
By jwhitleThe Novo Nordisk Foundation recently funded a grant — Real-time sustainability analysis for Industry 4.0 (Sustain 4.0) — that will enhance the collaboration between NC...